MedBridgeNZAre standard Alzheimer's meds plateauing? Explore Integrative Alzheimer's Treatment in China. Top hospitals are combining neurology & multi-target TCM to safely combat cognitive decline.
As a medical concierge provider, MedBridgeNZ doesn't treat—we facilitate. We expertly manage your Medical Tourism China journey, connecting you to top specialists.
Read the evidence: https://zurl.co/OtbUb
#Neurology #Alzheimers #MedicalConcierge #MedBridgeNZ #MedicalTourismChina #ChinaMedicalTourism
Integrative Alzheimer's Treatment in China: A Guide for International Patients
Home > Blog > Advanced Therapies & TechnologyKey Takeaways • Limitations of Single-Target Drugs: Mainstream single-target Alzheimer's medications often face a 6 to 12-month "efficacy plateau" and present significant side effect profiles, including gastrointestinal issues and Amyloid-Related Imaging Abnormalities (ARIA). • Integrative Clinical Evidence: A meta-analysis of 23 randomized controlled trials involving 2,035 patients demonstrated that integrating multi-target plant-based compounds with